|
AU2020104082A4
|
|
An Anti-HIV Monoclonal Antibody and a Method for Preparing and Use Thereof
|
|
CN112007042A
|
|
Application of cytarabine and proto-oncoprotein c-FOS inhibitor in preparation of product for treating leukemia
|
|
CN112023048A
|
|
Construction method and application of stable-transformation recombinant B lymphocyte leukemia cell line resistant to cytarabine
|
|
CN112089842A
|
|
Target point c-FOS related to leukemia treatment and application thereof
|
|
CN112043825A
|
|
Subunit vaccine for preventing novel coronavirus infection based on novel coronavirus spike protein S1 region
|
|
CN111840534A
|
|
Large-scale preparation method of F-genotype mumps attenuated live vaccine
|
|
CN112023035A
|
|
Nano vaccine taking S protein RBD region of SARS-CoV-2 virus as antigen and preparation thereof
|
|
CN111647078A
|
|
anti-HIV monoclonal antibody and preparation method and application thereof
|
|
CN111558036A
|
|
Herpes zoster vaccine composition, and preparation method and application thereof
|
|
CN111172251A
|
|
Method, kit and primer for detecting tree shrew SLC22A8 gene transcription level by RT-qPCR method
|
|
CN111139296A
|
|
Real-time fluorescent quantitative PCR primer and method for detecting transcription level of TGF- β gene of tree shrew
|
|
CN111154868A
|
|
Method for detecting tree shrew SLC22A6 gene transcription level by real-time fluorescence quantitative PCR method, primer and kit
|
|
CN111197084A
|
|
Primer, kit and method for detecting transcription level of NF-kB gene of tree shrew
|
|
CN111187846A
|
|
Primer, kit and method for detecting tree shrew LCN2 gene transcription level
|
|
CN111139233A
|
|
Broad-spectrum neutralizing anti-EV 71, CA16, CA10 and CA6 human-mouse chimeric IgM monoclonal antibody and application
|
|
CN111035755A
|
|
Type 1diabetes vaccine and preparation method thereof
|
|
CN111004775A
|
|
Method for physically removing oocyte zona pellucida
|
|
CN110656120A
|
|
Cloning method and application of Japanese encephalitis virus SA14-14-2
|
|
CN110639013A
|
|
HPV nano vaccine composition with IL-33 as adjuvant and preparation method thereof
|
|
CN110680918A
|
|
HPV nano vaccine composition with ATP as adjuvant and preparation method thereof
|
